These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21212518)
1. Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats. Hori Y; Yoshioka K; Kanai K; Hoshi F; Itoh N; Higuchi S Biol Pharm Bull; 2011; 34(1):61-5. PubMed ID: 21212518 [TBL] [Abstract][Full Text] [Related]
2. Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats. Hori Y; Kunihiro S; Sato S; Yoshioka K; Hara Y; Kanai K; Hoshi F; Itoh N; Higuchi S Biol Pharm Bull; 2009 Oct; 32(10):1678-82. PubMed ID: 19801827 [TBL] [Abstract][Full Text] [Related]
3. Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. Veliotes DG; Norton GR; Correia RJ; Strijdom H; Badenhorst D; Brooksbank R; Woodiwiss AJ J Cardiovasc Pharmacol; 2010 Aug; 56(2):203-11. PubMed ID: 20531215 [TBL] [Abstract][Full Text] [Related]
4. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755 [TBL] [Abstract][Full Text] [Related]
5. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836 [TBL] [Abstract][Full Text] [Related]
6. Aminoguanidine inhibits ventricular fibrosis and remodeling process in isoproterenol-induced hypertrophied rat hearts by suppressing ROS and MMPs. Parthasarathy A; Gopi V; Devi K M S; Balaji N; Vellaichamy E Life Sci; 2014 Nov; 118(1):15-26. PubMed ID: 25445437 [TBL] [Abstract][Full Text] [Related]
7. Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats. Okada M; Kosaka N; Hoshino Y; Yamawaki H; Hara Y Biol Pharm Bull; 2010; 33(9):1517-21. PubMed ID: 20823567 [TBL] [Abstract][Full Text] [Related]
9. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression. Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916 [TBL] [Abstract][Full Text] [Related]
10. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1. Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331 [TBL] [Abstract][Full Text] [Related]
11. Exogenous ubiquitin modulates chronic β-adrenergic receptor-stimulated myocardial remodeling: role in Akt activity and matrix metalloproteinase expression. Daniels CR; Foster CR; Yakoob S; Dalal S; Joyner WL; Singh M; Singh K Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1459-68. PubMed ID: 23042947 [TBL] [Abstract][Full Text] [Related]
12. Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats. Ocaranza MP; Díaz-Araya G; Carreño JE; Muñoz D; Riveros JP; Jalil JE; Lavandero S Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H498-506. PubMed ID: 14527934 [TBL] [Abstract][Full Text] [Related]
13. Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model. Wang LX; Yang X; Yue Y; Fan T; Hou J; Chen GX; Liang MY; Wu ZK PLoS One; 2017; 12(6):e0178619. PubMed ID: 28570599 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. Bos R; Mougenot N; Findji L; Médiani O; Vanhoutte PM; Lechat P J Cardiovasc Pharmacol; 2005 Jan; 45(1):8-13. PubMed ID: 15613973 [TBL] [Abstract][Full Text] [Related]
15. Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991. Ferreira AJ; Oliveira TL; Castro MC; Almeida AP; Castro CH; Caliari MV; Gava E; Kitten GT; Santos RA Life Sci; 2007 Aug; 81(11):916-23. PubMed ID: 17825326 [TBL] [Abstract][Full Text] [Related]
16. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
17. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Lekgabe ED; Kiriazis H; Zhao C; Xu Q; Moore XL; Su Y; Bathgate RA; Du XJ; Samuel CS Hypertension; 2005 Aug; 46(2):412-8. PubMed ID: 15967869 [TBL] [Abstract][Full Text] [Related]
18. Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis. Dai H; Chen L; Gao D; Fei A Biomed Res Int; 2019; 2019():5408289. PubMed ID: 30729126 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice. Liu HL; Chen CH; Sun YJ Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4414-4418. PubMed ID: 31173316 [TBL] [Abstract][Full Text] [Related]
20. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats. Gallego M; Espiña L; Vegas L; Echevarria E; Iriarte MM; Casis O Pharmacol Res; 2001 Oct; 44(4):311-5. PubMed ID: 11592866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]